Cargando…
Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients
BACKGROUND: Severe coronavirus disease 2019 (COVID‐19) is characterized by marked hypoxaemia and lung oedema, often accompanied by disordered blood coagulation and fibrinolytic systems, endothelial damage and intravascular fibrin deposition. PATIENTS/METHODS: We present a retrospective observational...
Autores principales: | Gardiner, Chris, Mackie, Ian J., MacCallum, Peter, Platton, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111592/ https://www.ncbi.nlm.nih.gov/pubmed/35451557 http://dx.doi.org/10.1111/ijlh.13855 |
Ejemplares similares
-
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
por: Bowles, Louise, et al.
Publicado: (2020) -
Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019
por: Zhong, Yajuan, et al.
Publicado: (2021) -
A multicenter study to evaluate automated platelet aggregometry on Sysmex CS‐series coagulation analyzers—preliminary findings
por: Platton, Sean, et al.
Publicado: (2018) -
Fibrinolytic and coagulative activities of Yersinia pestis
por: Korhonen, Timo K., et al.
Publicado: (2013) -
The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease
por: Schuliga, Michael
Publicado: (2015)